BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34083299)

  • 21. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
    Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
    Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones.
    Jemaa AB; Bouraoui Y; Rais NB; Nouira Y; Oueslati R
    Immunobiology; 2016 Dec; 221(12):1424-1431. PubMed ID: 27451139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.
    Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
    Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.
    Eminaga O; Hinkelammert R; Abbas M; Wötzel F; Eltze E; Bettendorf O; Boegemann M; Semjonow A
    Urology; 2015 Oct; 86(4):798-804. PubMed ID: 26255036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
    Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.
    Lazzeri M; Haese A; Abrate A; de la Taille A; Redorta JP; McNicholas T; Lughezzani G; Lista G; Larcher A; Bini V; Cestari A; Buffi N; Graefen M; Bosset O; Le Corvoisier P; Breda A; de la Torre P; Fowler L; Roux J; Guazzoni G
    BJU Int; 2013 Aug; 112(3):313-21. PubMed ID: 23826841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
    Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy.
    Navarro-Martínez R; Serrano-Carrascosa M; Buigues C; Fernández-Garrido J; Sánchez-Martínez V; Castelló-Domenech AB; García-Villodre L; Wong-Gutiérrez A; Rubio-Briones J; Cauli O
    Urol Oncol; 2019 Dec; 37(12):976-987. PubMed ID: 31521528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml.
    Lucarelli G; Fanelli M; Larocca AM; Germinario CA; Rutigliano M; Vavallo A; Selvaggi FP; Bettocchi C; Battaglia M; Ditonno P
    Prostate; 2012 Nov; 72(15):1611-21. PubMed ID: 22430630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
    Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
    Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
    Raymond WD; Eilertsen GØ; Nossent J
    Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet.
    Xu H; Hu MB; Bai PD; Zhu WH; Liu SH; Hou JY; Xiong ZQ; Ding Q; Jiang HW
    Biomed Res Int; 2015; 2015():249741. PubMed ID: 25722971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cytokine profiles in patients with prostate carcinoma.
    Tazaki E; Shimizu N; Tanaka R; Yoshizumi M; Kamma H; Imoto S; Goya T; Kozawa K; Nishina A; Kimura H
    Exp Ther Med; 2011 Sep; 2(5):887-891. PubMed ID: 22977593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
    Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
    Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels.
    Narita S; Tsuchiya N; Kumazawa T; Maita S; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    J Laparoendosc Adv Surg Tech A; 2013 Jan; 23(1):33-7. PubMed ID: 23259574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.